TNXP — Tonix Pharmaceuticals Holding Share News
0.000.00%
Last trade - 00:00- $191.45m
- $5.98m
- $13.11m
Tonix Pharmaceuticals Q1 net loss widens on higher SG&A expenses
Brief: Tonix Pharmaceuticals Announces Presentations At World Vaccine Congress Washington 2026
Tonix Pharmaceuticals Q4 revenue more than doubles, net loss widens
Brief: Tonix Pharmaceuticals Announces Uplisting From Nasdaq Capital Market To Nasdaq Global Select Market
U.S. STOCKS ON THE MOVE-Church & Dwight, Tesla, Oppenheimer
U.S. STOCKS ON THE MOVE-Charter Communications, Western Digital, Regeneron
U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology
Tonix pain‑relief drug meets main goal in late‑stage study; shares fall
Tonix Pharmaceuticals ticks up after $20 million direct stock deal
Brief: Tonix Pharmaceuticals Announces Licensing TNX-4900
Brief: Tonix Pharmaceuticals Announces FDA Ind Clearance For Phase 2 Study Of Tnx-102 Sl
Brief: Tonix Pharmaceuticals - Amends Sales Agreement With Alliance Global Partners - SEC Filing
Brief: Tonix Pharmaceuticals - Increases Share Repurchase Program To $35 Million - SEC Filing
U.S. STOCKS ON THE MOVE-TransAlta, Johnson & Johnson, E.W. Scripps
U.S. STOCKS ON THE MOVE-Sunoco, Albemarle, GE Healthcare Technologies
Tonix set for best day in over two months as new fibromyalgia drug hits U.S. market
Tonix rises as first new fibromyalgia drug in 15 years becomes available in U.S.
Tonix Pharmaceuticals Q3 net loss widens
Brief: Tonix, Mass General Partner on Phase 2 Trial of TNX-1500 to Prevent Kidney Transplant Organ Rejection